|

Placebo Comparator Clinical Trials

4 actively recruiting trials across 2 locations

Also known as: Placebo, microcrystalline cellulose tablets

Pipeline

Phase 1: 1Phase 2: 1Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Shanna Babalonis, PhD1
  • Indiana University1
  • BioArctic AB1
  • Assistance Publique - Hôpitaux de Paris1

Indications

  • NSTEMI1
  • AMI1
  • Left Ventricular Dysfunction1
  • STEMI1
  • Alzheimer's Disease1

Other2 trials

DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction
Phase 3
Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy
Phase 2

Indianapolis, Indiana1 trial

Nicotinic Acid for the Treatment of Alzheimer's Disease

IU Health Neuroscience Center

Phase 1/2

Lexington, Kentucky1 trial

Impact of Daily Oral Cannabis Doses in Patients With Cancer

University of Kentucky

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.